Anti-viral drug favipiravir gets DGCI nod for 'restricted...

New Delhi [India], June 19 (ANI): The Drug Controller General of India (DCGI) has granted permission to anti-viral...

Six Indian companies applied to CDSCO for permission to...

New Delhi [India], June 14 (ANI): The Centre on Sunday said that six Indian companies -- Hetero, Cipla, BDR,...

COVID-19: Pharma giants seek DCGI's approval to manufacture,...

New Delhi [India], June 4 (ANI): Two domestic pharmaceutical firms--Mylan and Jubilant Life Sciences have approached...

Zydus Cadila approaches DCGI to use hepatitis drug for...

New Delhi [India], May 5 (ANI): The country's top drug regulator, Drug Controller General of India (DCGI), has...

Top drug regulator to ensure no shortage of essential,...

New Delhi [India], April 18 (ANI): Warning against stockpiling of medicines and creating supply chain shortages, the...

Drug regulator asks states to give clearance to industrial...

New Delhi [India], April 7 (ANI): In a step to ensure adequate supply of `oxygen for medical use' for treating...

Lockdown effect: Top drug regulator instructs release of...

New Delhi [India], April 3 (ANI): In the wake of coronavirus lockdown, the Central Drugs Controller has instructed...

European drug regulator approves Biocon's Malaysia insulin...

Bengaluru (Karnataka) [India], Aug 22 (ANI): Biopharmaceutical major Biocon said on Thursday said its insulin...

Action will be taken after Johnson & Johnson baby powder's...

Baddi (Himachal Pradesh) [India], Dec 19 (ANI): Days after India's central drug regulator CDSCO seized samples of...

Panacea Biotec up 13 pct on US FDA nod for migraine drug

New Delhi [India], Jan 18 (ANI): Shares of Panacea Biotec zoomed over 13 percent intraday on Wednesday as the...